Systems biology and new technologies enable predictive and preventative medicine

Science

Volumn 306, Issue 5696, 2004, Pages 640-643

  Hood, Leroy ^a   Heath, James R ^b,c   Phelps, Michael E ^c   Lin, Biaoyang ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DISEASE CONTROL; GENES; PARAMETER ESTIMATION; PROTEINS;

DISEASE-PERTURBED PROTEIN; GENE REGULATORY NETWORKS; MULTIPARAMETER MEASUREMENTS;

MEDICINE;

MEDICINE;

BIOTECHNOLOGY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; NANOTECHNOLOGY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; DIAGNOSIS; DISEASE; DISEASE PROGRESSION; FORECASTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROFLUIDICS; NANOTECHNOLOGY; PREVENTIVE MEDICINE; PROSTATE; PROSTATIC NEOPLASMS; SYSTEMS ANALYSIS; SYSTEMS THEORY; THERAPEUTICS;

EID: 7444253428     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1104635     Document Type: Review

References (56)

1. E. H. Davidson et al., Science 295, 1669 (2002).
2. E. H. Davidson, D. R. McClay, L. Hood, Proc. Natl. Acad. Sci. U.S.A. 100, 1475 (2003).
3. H. Kitano, Science 295, 1662 (2002).
4. U. Alon, Science 301, 1866 (2003).
5. E. V. Rothenberg, E. H. Davidson, in Innate Immunity, R. A. B. Ezekowitz, J. A. Hoffnnan, Eds. (Humana, Totowa, NJ, 2003), pp. 61-88.
6. D. T. Odom et al., Science 303, 1378 (2004).
7. T. Ideker et al., Science 292, 929 (2001).
8. The prediction of classical secretory proteins was based on the existence of signal peptides and the number and position of transmembrane domains in a protein. The prediction of nonclassical secretory proteins (proteins without an N-terminal signal peptide) was based on the algorithm developed by J. D. Bendtsen et al. (http://www.cbs.dtu.dk/services/SecretomeP-1.0/).
9. A. D. Weston, N. S. Baliga, R. Bonneau, L. Hood, Cold Spring Harbor Symp. Quant. Biol. 68, 345 (2003).
10. C. A. Klein, Cell Cycle 3, 29 (2004).
11. P. A. Covitz, Pharmacogenomics J. 3, 257 (2003).
12. D. Hanahan, R. A. Weinberg, Cell 100, 57 (2000).
13. S. Brenner et al., Nature Biotechnol. 18, 630 (2000).
14. B. Lin et al., in preparation.
15. B. Lin et al., in preparation.
16. A. C. Utleg et al., in preparation.
17. E. F. Petricoin 3rd et al., J. Natl. Cancer Inst. 94, 1576 (2002).
18. B. L. Adam et al., Cancer Res. 62, 3609 (2002).
19. E. P. Diamandis, Clin. Chem. 49, 1272 (2003).
20. Y. Qu et al., Clin. Chem. 48, 1835 (2002).
21. H. Zhang, X. J. Li, D. B. Martin, R. Aebersold. Nature Biotechnol. 21, 660 (2003).
22. Using this method, Aebersold's group was able to identify 100 peptides in sera that were strongly associated with cancer status in a mouse model for chemically induced skin cancer.
23. J. C. Church, E. A. Stapleton, B. D. Reilly, Cytometry 14, 271 (1993).
24. L. Whetsell, C. Maw. N. Nadon, D. P. Ringer, F. V. Schaefer. Oncogene 7, 2355 (1992).
25. N. L. Simone. R. F. Bonner, J. W. Gillespie, M. R. Emmert-Buck, L. A. Liotta, Trends Genet. 14, 272 (1998).
26. A. Y. Liu et al., Proc. Natl. Acad. Sci. U.S.A. 94, 10705 (1997).
27. R. A. Craven, R. E. Banks, Proteomics 1, 1200 (2001).
28. A. G. Hadd, D. E. Raymond, J. W. Halliwell, S. C. Jacobson, J. M. Ramsey, Anal. Chem. 69, 3407 (1997).
29. I. Karube, K. Ikebukuro, Y. Murakami, K. Yokoyama, Ann. N.Y. Acad. Sci. 750, 101 (1995).
30. L. C. Waters et al., Anal. Chem. 70, 158 (1998).
31. R. H. Carlson. C. V. Gabel, S. S. Chan, R. H. Austin, J. P. Brody, Phys. Rev. Lett. 79, 2149 (1997).
32. A. Y. Fu, H. P. Chou, C. Spence, F. H. Arnold, S. R. Quake, Anal. Chem. 74, 2451 (2002).
33. J. W. Hong, V. Studer, G. Hang, W. F. Anderson, S. R. Quake. Nature Biotechnol. 22, 435 (2004).
34. J. Fritz et al., Science 288, 316 (2000).
35. Y. Cui, Q. Wei, H. Park, C. M. Lieber, Science 293, 1289 (2001).
36. R. J. Chen et al., Proc. Natl. Acad. Sci. U.S.A. 100, 4984 (2003).
37. G. Wu et al., Nature Biotechnol. 19, 856 (2001).
38. J. Hahm, C. M. Lieber, Nano Lett. 4, 51 (2004).
39. R. McKendry et al., Proc. Natl. Acad. Sci. U.S.A. 99, 9783 (2002).
40. Y. Arntz et al., Nanotechnology 14, 86 (2003).
41. N. A. Melosh et al., Science 300, 112 (2003).
42. Y. Bunimovich et al., Langmuir, in press.
43. K. B. Lee, S. J. Park, C. A. Mirkin, J. C. Smith, M. Mrksich, Science 295, 1702 (2002).
44. R. Pantoja et al., Biosensors and Bioelectronics, in press; published online 6 May 2004; doi.10.1016/ j.bios.2004.02.020 (http://dx.doi.org/10.1016/ j.bios.2004.02.020).
45. I. Braslavsky, B. Hebert, E. Kartalov, S. R. Quake, Proc. Natl. Acad. Sci. U.S.A. 100, 3960 (2003).
46. S. A. Wickline, G. M. Lanza, Circulation 107, 1092 (2003).
47. G. Choy et al., Biotechniques 35, 1022 (2003).
48. R. Weissleder, U. Mahmood, Radiology 219, 316 (2001).
49. H. R. Herschman, Science 302, 605 (2003).
50. T. F. Massoud, S. S. Gambhir, Genes Dev. 17, 545 (2003).
51. M. E. Phelps, Proc. Natl. Acad. Sci. U.S.A. 97, 9226 (2000).
52. M. E. Phelps, PET: Molecular Imaging and Biological Applications (Springer, New York, 2004).
53. K. Shah, A. Jacobs, X. O. Breakefield, R. Weissleder, Gene Ther. 11, 1175 (2004).
54. P. Shannon et al., Genome Res. 13, 2498 (2003).
55. E. Johnston-Halperin et al., J. Appl. Phys., in press.
56. We thank all the members of the NanoSystems Biology Alliance for their insights, expertise, and encouragement. We acknowledge support from the National Cancer Institute, the Army Research Office, and the Department of Energy.